Analytical Data
-
基因名
IGSF12
- Application
-
别名
IGSF12；CMRF35H；IGSF12；CMRF35-like molecule 8
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UGN4
-
表达区间
1-178aa
-
氨基酸序列
MWLPWALLLL WVPGCFALSK CRTVAGPVGG SLSVQCPYEK EHRTLNKYWC RPPQIFLCDK IVETKGSAGK RNGRVSIRDS PANLSFTVTL ENLTEEDAGT YWCGVDTPWL RDFHDPVVEV EVSVFPASTS MTPASITAAK TSTITTAFPP VSSTTLFAVG ATHSASIQEE TEEVVNSQ
-
分子量
19 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGSF12, or Immunoglobulin Superfamily Member 12, is a protein that belongs to the immunoglobulin superfamily and is implicated in various cellular processes, including cell adhesion, signaling, and immune responses. The study of IGSF12 has gained attention due to its potential roles in immune regulation and tumor biology. Research indicates that IGSF12 may be involved in modulating immune cell functions and influencing the tumor microenvironment, thus playing a crucial role in cancer progression and metastasis. Understanding the structure and function of IGSF12, especially through the development of recombinant protein technology, enables researchers to investigate its biochemical properties, interactions, and potential therapeutic applications. By producing recombinant IGSF12, scientists can explore its role in immune responses and evaluate its potential as a biomarker or target for cancer immunotherapy. The insights gained from this research could contribute to novel strategies for harnessing the immune system in combating various malignancies and enhancing our understanding of immune-related diseases. Overall, the investigation of IGSF12 and its recombinant forms represents a promising area of study with implications for both basic and translational research in immunology and oncology.
